Acasti Pharma Inc. (ACST)


Stock Price Forecast

May 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Acasti Pharma Inc. chart...

About the Company

We do not have any company description for Acasti Pharma Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

33

Exchange

Nasdaq

$-2M

Total Revenue

33

Employees

$20M

Market Capitalization

-1.71

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ACST News

Acasti Pharma Inc Class A ACST

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Insider Stock Buying Reaches US$2.50m On Acasti Pharma

4d ago, source:

In the last twelve months Acasti Pharma insiders were buying shares, but not selling. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, ...

Acasti Pharma (NASDAQ: ACST)

22d ago, source: The Motley Fool

Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.

Acasti Pharma Inc. Class A

3y ago, source: CNN

Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.

Acasti Pharma Inc - Ordinary Shares - Class A

3y ago, source: U.S. News & World Report

Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.

Acasti Pharma, Inc. Class A Common Stock (ACST)

5mon ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

Acasti Pharma Inc - Ordinary Shares - Class A

4d ago, source: U.S. News & World Report

Owning high-quality stocks from each of the 11 sectors is a smart way to improve diversification and mitigate risk.

Acasti Pharma Inc.

26d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Acasti Pharma Inc. (ACST)

29d ago, source: Yahoo Finance

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Acasti Pharma Inc Class A

11d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...